OCT 31
end channels
New Users Please Click to Register
Renew or Upgrade your Existing  Account
facebook link
HDCN Facebook
off Symposia
Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    RRI-2015  :  Brigham-2014  :  RRI-2014  :  Brigham-2013  :  ISHD Shanghai-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-Chicago-2012/14  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
what new
free ISHD Hemodialysis University Chicago (2012-2014)
free ISHD Hemodialysis University Shanghai 2013
free ISHD Hemodialysis University Chicago (2014)
free ISHD Hemodialysis University India (2014)


Harvard Brigham Nephrology Board Review Course (Part 4)   key
Flash or IPAD slide/audio
Boston, MA; August 2014

Paraprotein - Associated Kidney Diseases
Laura M. Dember, MD




Advances in CKD 2015 (PART 6)   key
Flash or IPAD slide/audio
New Orleans, LA; January 2015

Keynote Address: The Bio-Engineered Kidney
Harald C. Ott, MD

NIDDK - Different Aspects of CKD Management
Miguel A. Vazquez, MD



Hypertension, Cardiovascular
o_ Low-carb diet better for diabetes
o_ Hypertension in the elderly and polypharmacy
o_ Cryoballoon treatment of a. fib.
o_ Fasting until noon triggers post-prandial glucose
o_ Salt-ingestion vs. excretion and cycling
o_ Stopping anti-HTN drugs in the elderly
o_ ACE-I not so good in Blacks
o_ Ezetimibe addition to simvastatin good
o_ Misconceptions about a. fib.
o_ Prevention of CV disease in type 2 DM (update)
o_ BP control and recurrent IC hemorrhage
o_ Allopurinol use and hypersensitivity reactions

CKD, Dialysis
o_ Low dialysate Ca bad
o_ Good dental health good
o_ Infective endocarditis: AHA Statement
o_ Cardiac resynchronization in stage 4 CKD
o_ IV iron given during infection
o_ Untrained attending nephrologists bad at inserting catheters
o_ Subcu EPO gives better hard outcomes
o_ Optimizing dialysate composition
o_ AGEs and outcome in diabetes
o_ Ferric citrate reduces need for IV iron and ESAs
o_ Serum Mg modifies phosphorus risk
o_ Ionic conductivity of peritoneal dialysate
o_ KDOQI 2015 hemodialysis adequacy update
o_ Vitamin D care in primary practice
o_ Integrated home dialysis care outcomes
o_ Mineral dysregulation in CKD (key)
o_ Michigan appropriatenes guide for catheters
o_ Dietary sodium restriction lowers albuminuria (meta)
o_ Finerenone lowers albuminuria in diabetes
o_ Hard outcomes and the long interdialytic gap

Clinical Nephrology
o_ Eculizumab in pediatric dense deposit disease
o_ Hyponatremia in PD and cognitive impairment
o_ Eculizumab in crescentic IGAN
o_ Buffered crystalloid vs. saline and subsequent AKI
o_ Atlas of Renal Pathology: IGAN
o_ Mycophenolate no good for IGAN
o_ Aristolochia clematis in an Italian garden
o_ Remission of proteinuria in membranous
o_ Bicarb vs. saline against contrast nephropathy
o_ Euglycemic diabetic ketoacidosis
o_ Rituximab for steroid-dependent NS in kids
o_ Familial aggregation of SLE

channel news

recent audio

ASN abstracts

key This update's selected ASN 2015 abstracts

(2015 abstracts will begin in November after the ASN)

 (Kidney Week 2014...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: November 24, 2015 (Nov24)
Nov24 Histone deacytelase (HDAC) inhibitors prevent muscle wasting.
Nov24 Cooking with chloraminated water can contaminate food with toxic molecules.
Nov23 HDCN is on Facebook.
Nov22 Renal pathologists soon will be replaced by pigeons.
Nov21 Orphan drug designation may lead to high drug prices, like for rituximab.
Nov10 STHLM3 test for prostate cancer will be in Sweden by March of 2016.
Nov10 Barbecued and pan-fried meat increases risk of kidney cancer.
Nov10 L-DOPA may delay onset of age-related macular degeneration by 8 years.
Nov10 Sprint Blood Pressure Trial article link at NEJM
Nov10 Sprint study presented at the AHA Scientific Sessions and published in NEJM.
Nov06 Virtual doctor visists on the increase.
Oct20 Advances in gene manipulation hasten suitability of pig organs for transplant.
Oct09 ASN Kidney Week 2015 abstracts now available on-line
Sep25 Giving BP meds at bedtime particularly effective in lowering diabetes risk
Sep22 Japanese scientist on pathway to solving urinary excretion for stem-cell generated kidneys
Sep17 Program for "Hemodialysis University" this October 2nd and 3rd in Chicago
Sep17 Empagliflozin use in diabetes associated with large reduction in CV risk.
Sep11 SPRINT RCT data support an even lower BP target (120 systolic) for the elderly.
Sep08 Feds propose a new set of rules to protect human subjects during research.
Sep05 Multistate outbreak of salmonella linked to cucumbers.
General Advances Emphasis
featured articles
Seminars in Dialysis
key Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease Dr. Felsenfeld and colleagues provide a nice overview of mineral bone disorder in this issue which explores many facets of bone disease in CKD; in the Nov/Dec issue of Seminars in Dialysis. (more...)

key Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials
Dr. Kotanko and the FHN Study Group describe the effects of frequent short daily and long nocturnal HD on blood pressure. There were some surprising findings regarding the incidence of intradialytic hypotension; in the July-August issue of Hemodial Int (more...)

Seminars in Dialysis
key Considerations for systemic anticoagulation in ESRD Warfarin, dabigatran, aspirin? Watchful waiting? Other drugs? So many drugs and so little information. Dager and colleagues help guide us through the maze; in the Sept/Oct issue of Seminars in Dialysis. (more...)

key Anticoagulation in chronic hemodialysis: progress toward an optimal approach
In this extremly timely review, Kessler and her colleagues discuss five key issues regarding anticoagulation: standardization, individualization, role of the extracorporeal circuit, options for heparin reduction or avoidance, and optimization of therapy; in the July/August issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Preserving residual renal function in dialysis: what we know
Drs. Patel and Hu review what we can do at the present state of incomplete knowledge; in the May/Jun issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Unnecessary renal replacement therapy for acute kidney injury is harmful for renal recovery
Drs. Clark and Bagshaw discuss the potential harms of dialysing patients with suspected AKI too early; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Dietary protein and fiber in end stage renal disease
Tammy Sirich talks about dietary protein, fiber, gut transit time, and gut microbes in uremia, and new ways to modulate blood levels of indoxyl sulfate and p-cresyl sulfate; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key Thyroid function tests in end stage renal disease.
Drs. Kulkarni and Holley describe the emerging evidence that thyroid dysfunction should be sought and perhaps treated in dialysis patients; in the Nov/Dec issue of Seminars in Dialysis, which has articles about the usefulness of many other laboratory tests in ESKD as well.. (more...)

Hemodialysis International
key Hypomagnesemia, chronic kidney disease and cardiovascular mortality: Pronounced association but unproven causation
Dr. Dousdampanis and colleagues review the latest evidence regarding low magnesium and CKD, and whether we should treat it; in the October issue of Hemodial Int (more...)

Seminars in Dialysis
key Sailing between Scylla and Charybdis: The high serum K - low dialysate K quandary
Should we use a 3 K bath for most patients? Are 1K and zero K bath's a no-no? Drs. Labriola and Jadoul review the evidence in the Sept/Oct issue of Seminars in Dialysis. (more...)

Seminars in Dialysis
key A stepwise approach for the management of poisoning with extracorporeal treatments Few are using hemoperfusion anymore, and poisoning requires an integrated approach. Dr. Ghannoum and colleagues provide a nice overview in the July/Aug issue of Seminars in Dialysis. (more...)

Hemodialysis International
key Hemodialysis for infants, children, and adolescents
Drs. Kaur and Davenport review techniques for performing hemodialysis in children; in the July issue issue of Hemodial Int (more...)

Seminars in Dialysis
key Urgent-start peritoneal dialysis: what are the problems and their solutions? Dr. Mahnensmith discusses this new approach to AKI or acute-on-chronic kidney failure, its advantages and potential problems; in the May/June issue of Seminars in Dialysis. (more...)

Hemodialysis International
key Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome
Dr. Sands and colleagues delve into large databases to better understand the occurrence and risk factors for intradialytic hypotension; in the April issue of Hemodial Int (more...)

free   SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

key   Advances in CKD (Renal Research Institute) (2015) (2014) (2013) (2012) (2011) (2010) (2009)
free   Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
key   The Brigham Renal Board Review Course: Selected Lectures (2014) -- (2013) -- (2012) -- (2011)
key   American Society of Hypertension (2013)   (2012)   (2011)
key   Renal Physicians Association (2012) (2011) (2010) (2009)
key   American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
free   Fistula First (2010)
key   Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
key   National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
key   American Society for Nephrology Renal Week (2009) (2008) (2007)
key   American Society for Nephrology Board Review Course (2008) (2007)
key   American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
key   Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com